Deep knowledge on 
 small-molecule drugs and 
 the 110,000 global patents 
 covering them 

Free Patent Expiration Alerts


Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Lidocaine hydrochloride - Generic Drug Details

« Back to Dashboard
Lidocaine hydrochloride is the generic ingredient in thirty-five branded drugs marketed by Intl Medication, Fresenius Kabi Usa, Hospira, Roxane, Graham Chem, Eurohlth Intl Sarl, Abraxis Pharm, Vintage, Bel Mar, Miles, Hi Tech Pharma, Powder Pharms, Oak Pharms, Astrazeneca, G And W Labs Inc, Akorn, Carlisle, Elkins Sinn, Watson Labs, Pharmaton, Bionpharma Inc, B Braun, Kendall Il, Gd Searle Llc, Watson Labs Inc, Aurobindo Pharma Ltd, Mylan Labs Ltd, Meridian Medcl Techn, Luitpold, Abbott, Baxter Hlthcare, Luitpold Pharms Inc, Wockhardt, Actavis Mid Atlantic, Dentsply Pharm, Wyeth Ayerst, Dell Labs, Paco, Lyphomed, Sagent Pharms, Teligent Pharma Inc, and Pfizer, and is included in ninety-eight NDAs. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

This ingredient has seventy-two patent family members in thirty-four countries.

There are twenty-nine drug master file entries for lidocaine hydrochloride. Forty-nine suppliers are listed for this compound.

Summary for Generic Name: lidocaine hydrochloride

Tradenames:35
Patents:5
Applicants:42
NDAs:98
Drug Master File Entries: see list29
Suppliers / Packaging: see list49
Therapeutic Class:Anesthetics
Formulation / Manufacturing:see details

Clinical Trials for: lidocaine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun
LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER
lidocaine hydrochloride
INJECTABLE;INJECTION018967-001Mar 30, 1984DISCNNo<disabled><disabled>
Hospira
LIDOCAINE HYDROCHLORIDE
lidocaine hydrochloride
INJECTABLE;INJECTION088330-001May 17, 1984DISCNNo<disabled><disabled>
Fresenius Kabi Usa
XYLOCAINE
lidocaine hydrochloride
INJECTABLE;INJECTION006488-002Approved Prior to Jan 1, 1982RXYes<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: lidocaine hydrochloride

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Powder Pharms
ZINGO
lidocaine hydrochloride
SYSTEM;INTRADERMAL022114-001Aug 16, 20075,899,880<disabled>
Powder Pharms
ZINGO
lidocaine hydrochloride
SYSTEM;INTRADERMAL022114-001Aug 16, 20075,630,796<disabled>
Powder Pharms
ZINGO
lidocaine hydrochloride
SYSTEM;INTRADERMAL022114-001Aug 16, 20076,881,200<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: lidocaine hydrochloride

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,044,546Particle cassettes and processes therefor<disabled in preview>
7,942,846Needleless syringe using supersonic gas flow for particle delivery<disabled in preview>
6,168,587 Needleless syringe using supersonic gas flow for particle delivery<disabled in preview>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: lidocaine hydrochloride

Country Document Number Estimated Expiration
Romania118569<disabled in preview>
Spain2098131<disabled in preview>
Poland311005<disabled in preview>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2016 thinkBiotech LLC
ISSN: 2162-2639

Connect with Social Media:

`abc